NASDAQ: ELVN · Health Care / Biotechnology: Pharmaceutical Preparations

Enliven Therapeutics Inc.

How Enliven Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$3.3B

Price

$45.08

P/E

-31.2

EPS (TTM)

$-1.45

1-year return

99.0%

Dividend yield

0.0%

52-week range

$21.27–$46.97

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources